InMed Pharmaceuticals Inc. Common Shares (INM)
INM trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$1.33
-2.21% on the day
Market cap
$7.3M
Nano cap
Revenue · 2025
$4.9M
+7.5% on 2024
Net income · 2025
-$8.2M
-165.1% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | INM on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | Canada |
| IPO year | Not reported by the screener |
| SEC CIK | 0001728328 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | A1 |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $4.9M |
| Net income | -$8.2M |
| Operating income | Not in SEC XBRL data |
| Net margin | -165.1% |
| Operating margin | Operating income not reported |
| Revenue growth | +7.5% |
| Cash | $7.0M |
| Total assets | $11.2M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 1.5× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B3 | 2026-10-01 |
| Latest annual report ANNUAL REPORT | 10-K | 2026-09-09 |
| Latest quarterly / interim QUARTERLY REPORT | 10-Q | 2026-05-06 |
| Latest current report CURRENT REPORT | 8-K | 2026-09-18 |
| Latest proxy DEFINITIVE ADDITIONAL MATERIALS | DEFA14A | 2025-11-03 |
Source: SEC EDGAR submissions feed, 504 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| SNGX | Soligenix Inc. | $0.3348 | -4.80% | $7.3M |
| APUS | Apimeds Pharmaceuticals US Inc. | $4.62 | -11.15% | $7.1M |
| XCUR | Exicure Inc. | $1.15 | +5.50% | $7.5M |
| APRE | Aprea Therapeutics Inc. | $0.6000 | +1.16% | $7.6M |
| CALC | CalciMedica Inc. | $1.12 | -7.05% | $7.6M |
| CURX | Curanex Pharmaceuticals Inc | $4.88 | 0.00% | $7.7M |
| TCRT | Alaunos Therapeutics Inc. | $3.03 | +188.57% | $7.7M |
| LGVN | Longeveron Inc. | $2.15 | -12.24% | $6.9M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier